Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Hypertension, Insomnia, Magnetic resonance imaging, Pneumonitis
Clinical narrative: ANXIETY ATTACK; NOT ABLE TO DO WALKING; TIRED/SORE FEELING ALL OVER BODY WHEN WALKS OR DO SOMETHING; PAIN AND SORENESS IN NECK/SHOULDER; BLOOD PRESSURE WAS 200/100; INFLAMMATION AROUND LUNGS; COULD NOT SLEEP; This spontaneous report received from a patient concerned a 73 year old female. The patient's weight was not reported and height was 65 inches. The patient's past medical history included neck surgery years ago, and multiple sclerosis diagnosed in 2003, and concurrent conditions included arthritic pain (has not had symptoms since 2010), diabetes type-II, non alcohol user, and non-smoker. The patient was not pregnant at the time of reporting and had no history of drug abuse or illicit drug use. The patient experienced drug allergy when treated with codeine, and influenza vaccine and she had stopped taking vaccines since vaccine made her sick. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, 1 total administered on 03-MAR-2021 to left arm for prophylactic vaccination. Concomitant medications included semaglutide for diabetes type-ii, and gabapentin. On 03-MAR-2021, at the night after vaccination she felt pain and soreness in her neck, shoulder, and chest and it escalated for several days. On an unspecified date in the same week of vaccination during a friday or saturday (MAR-2021), the patient could not sleep with hard time breathing. The patient went to emergency room and her blood pressure was 200/100 mmHg (millimeters of mercury). The patient was kept on emergency room and did a lot of unspecified tests and wanted the patient to put on a treatment to bring her blood pressure normal, but the patient did not feel like taking medicine and was hospitalized on an unknown date in MAR-2021. The patient also had a inflammation around her lungs and wanted to treat her. The patient was discharged on an unspecified date in MAR-2021 with a treatment medication of indomethacin 75 mg(milligram) 3 daily for 10 days. The patient felt better towards the end of the medicine. On an unspecified date, the patient had anxiety attack at the night and as a result her chest was hurt and had a hard time breathing. She went to primary care physician and was told to continue taking it. And also was told to call 911 or doctor's office if something happened. The patient's neurologist had ordered CT (computerized tomography) scan and MRI (Magnetic resonance imaging) and the results were not came at the time of this report. The primary care physician said it looked okay, but her neurologist said they needed time to talk to her about the results. The patient had residual effects of the vaccine which was dull pain sore in chest. She was walking and she was not able to do her walking without giving out, but was better with that. The residual pain in the chest was not as often. She was having coughing spells and her physician said there might still be some inflammation. The patient was on gabapentin which she only used it a few times, but at the time of this report she was taking it more.  The patient also got tired and sore feeling all over her body when she walks or do something. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from pain and soreness in neck/shoulder, and not able to do walking, had not recovered from inflammation around lungs, and tired/sore feeling all over body when walks or do something, and the outcome of anxiety attack, could not sleep and blood pressure was 200/100 was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210733674-COVID-19 VACCINE AD26.COV2.S. Blood pressure was 200/100. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.